HIMS logo

Hims & Hers Health

HIMS · What the business does, what can go wrong, and how options sellers approach it

What it does

Hims & Hers Health runs a consumer telehealth platform. Customers complete an online intake, and a licensed provider in the company's network reviews the request and decides whether to prescribe treatment. Orders are then filled and shipped through the company's pharmacy and fulfillment network.

The offering spans areas such as sexual health, hair loss, dermatology, mental health and weight management. It includes prescription medicines (generic, branded and compounded versions) as well as over-the-counter products, cosmetics and supplements. Customers pay directly, not through insurance.

How it makes money

Most revenue comes from online sales of products and services, many on a subscription or recurring-order basis. Customers pay out of pocket, so the company sets its own prices. Profit depends on gross margin (price minus product, pharmacy and provider costs), plus how much it spends on marketing to win customers. Keeping existing subscribers matters because it lowers the cost of growth.

Why investors own it

  • Exposure to the growth of direct-to-consumer healthcare and the shift toward online care.
  • A vertically integrated model, with its own platform, pharmacy and fulfillment, which can improve control over cost and customer experience.
  • Room to add new conditions and product categories to an existing customer base.

What can go wrong

  • Regulation: rules on telehealth, prescribing, advertising and compounded drugs can change, and enforcement or supply shifts can hit the business quickly.
  • Reliance on third-party drug makers and suppliers, especially for popular new treatments.
  • Heavy marketing spend and competition from other telehealth firms, retailers and drug makers selling directly to patients.
  • Customer retention may weaken if offers become easier to find elsewhere.
  • The stock is often volatile and can move sharply on news.

What to watch

  • Subscriber growth and retention
  • Revenue growth by category
  • Gross margin trends
  • Marketing spend relative to revenue
  • Regulatory or FDA actions affecting compounded or branded drugs
  • New product launches and international expansion
  • Free cash flow and profitability

Options income angle

Options on HIMS are generally actively traded, with thinner liquidity in far-dated or far out-of-the-money contracts. Implied volatility tends to be high, driven by earnings, regulatory headlines, drug supply news and retail sentiment. A caution for premium sellers: a sudden news-driven gap can push the stock well past a strike, causing losses that outweigh the income collected.

Follow HIMS in Kortex

The Kortex app shows HIMS's price, options chain and IV rank, and answers your questions from live market data and SEC filings.

Free to download.

Learn the strategies

More stock briefs

For education only, not financial advice. Options involve risk and are not suitable for every investor.